Global  Video

“The world's speediest news portal”
One News Page
> >

Lung cancer patients live longer with immune therapy

CBC.ca Monday, 16 April 2018 ()
For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Wochit News - < > Embed
News video: Lung Cancer Patients Fair Better with Immune Therapy

▶ Lung Cancer Patients Fair Better with Immune Therapy 00:45

According to a new report, lung cancer patients live longer while on immune therapy. Using a combination of immunotherapy drugs, doctors found that pre-treating lung cancer patients before surgery can help eat away at tumors, while helping patients recover from the affects of chemotherapy. A lung...

Recent related news

Lung Cancer Patients Live Longer With Immune Therapy

Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
NYTimes.com - US

New studies show hope for turning immune system against lung cancer

The idea of turning the immune system against cancer got a big boost over the last few days, with a trio of studies showing the approach’s effectiveness...
USATODAY.com - Front PageAlso reported by •SeattlePI.comSeattle TimesScience Daily

Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of Progression or Death by 42% Versus Chemotherapy in First-Line Lung Cancer Patients with High Tumor Mutational Burden (TMB)

Opdivo Plus Low-Dose Yervoy Combination Reduces the Risk of Progression or Death by 42% Versus Chemotherapy in First-Line Lung Cancer Patients with High Tumor Mutational Burden (TMB)
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #AACR18--Opdivo + Low-Dose Yervoy Combo Reduces the Risk of Progression or Death by 42% Versus Chemotherapy in First-Line...
Business Wire - Press Releases

Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors

EAGAN, Minn., April 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced the presentation of new translational data from ongoing phase 2...
GlobeNewswire - Press Releases

Merck shares pop as its Keytruda drug results power ahead of Bristol-Myers, Roche

Merck & Co (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY) and Roche Holding AG (VTX: ROG) cancer drugs all beat expectations, but Merck beat them a little more...
Proactive Investors - Business

Is whole-brain radiation still best for brain metastases from small-cell lung cancer?

A new study compares outcomes of 5,752 small-cell lung cancer patients who received whole-brain radiation therapy (WBRT) with those of 200 patients who received...
Science Daily - Science

Cynvenio and MD Anderson in Final Clinical Validation of LungLB(TM) Liquid Biopsy Lung Cancer Detection Diagnostic

LungLB(TM) will be the first cell-based non-invasive, blood test to rule-out patients with indeterminate lung nodules from having cancer. Over 20,000 patients...
PRWeb - Press Releases

You Might Like


Tweets about this


Other recent news in Health

LONDON Marathon: How to run in the heatSUPREME COURT junks Dawood Ibrahim kin's plea on attachment of properties
Biogen boosts investment in NEUROLOGY with $1 billion Ionis dealGiant Eagle Voluntarily Recalls Items Prepared with ROMAINE LETTUCE Due to Potential E. coli Contamination
Betting On Artificial Intelligence To Guide EARTHQUAKE ResponseGERMANY's Merck seeks partners for cancer and immune system drugs

Recent related videos

News video: New studies show hope in fighting lung cancer

▶ New studies show hope in fighting lung cancer 03:52

Doctors have a powerful new approach to fighting lung cancer, the leading cause of cancer deaths. Two studies released Monday show drugs that boosted patients' immune systems can dramatically improve..
Source: CBS News -

News video: Merck Expands Lead in Lung Cancer Therapy

▶ Merck Expands Lead in Lung Cancer Therapy 02:26

Apr.16 -- Merck & Co. is cementing its lead in lung cancer therapy, fending off rival Bristol-Myers Squibb Co. after new data that could reshape treatment of the deadly disease. Bloomberg's Taylor..
Source: Bloomberg Global Business -

News video: Immunotherapy Advances For Lung Cancer Patients

▶ Immunotherapy Advances For Lung Cancer Patients 00:32

According to Business Insider, "New cancer treatments that harness the body's immune system are ready to go mainstream... cancer drugmakers showed that the use of immunotherapy in combination with..
Source: Wochit News -

News video: This ‘Superblood’ Treatment Could Work Like Medicine

▶ This ‘Superblood’ Treatment Could Work Like Medicine 01:41

There are plenty of great scenically-driven developments that could help people with cancer treat it more effectively. New trials are being created constantly that alter cells, and try to galvanize..
Source: NowThis News -

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+